Characteristic Hepatic Atrophy in Abemaciclib‐Induced Liver Injury: A Comparative Review of Three Cases

Documenti analoghi

• Toward a Synthetic Data Revolution: Diffusion Model‐Enhanced Hepatocellular Carcinoma Prediction in Steatotic Liver Disease
  di: Masaya Sato, et al.
  Pubblicazione: (2026)
• Response to “Letter to the Editor: Pre‐Treatment Liver Stiffness is a Stronger Predictor of Hepatocellular Carcinoma Development Than Post‐Treatment Liver Stiffness After Hepatitis C Virus Eradication”
  di: Takuma Nakatsuka, et al.
  Pubblicazione: (2025)
• Hepatic Inflammation and Liver Injury in a Model of Bacterial Infection Triggered Acute‐on‐Chronic Liver Injury
  di: S. C. Karatayli, et al.
  Pubblicazione: (2025)
• Integrated policy of medical expense subsidies and clinical registry for patients with liver cancer and decompensated cirrhosis in Japan
  di: Yasue Takeuchi, et al.
  Pubblicazione: (2024)
• Comparative analysis of sorafenib and lenvatinib on HepG2 cells and human umbilical vein endothelial cells: Involvement of transforming growth factor‐β signaling in their molecular effects
  di: Ting Wang, et al.
  Pubblicazione: (2024)